闫文文, 张彦龙, 曹明慧, 刘政翰, 雷虹, 贾向前. 新型水凝胶的制备及其发挥免疫化疗协同作用的研究J. 药学学报, 2025, 60(2): 479-487. DOI: 10.16438/j.0513-4870.2024-0658
引用本文: 闫文文, 张彦龙, 曹明慧, 刘政翰, 雷虹, 贾向前. 新型水凝胶的制备及其发挥免疫化疗协同作用的研究J. 药学学报, 2025, 60(2): 479-487. DOI: 10.16438/j.0513-4870.2024-0658
YAN Wen-wen, ZHANG Yan-long, CAO Ming-hui, LIU Zheng-han, LEI Hong, JIA Xiang-qian. Preparation of new hydrogels and their synergistic effects of immunochemotherapyJ. Acta Pharmaceutica Sinica, 2025, 60(2): 479-487. DOI: 10.16438/j.0513-4870.2024-0658
Citation: YAN Wen-wen, ZHANG Yan-long, CAO Ming-hui, LIU Zheng-han, LEI Hong, JIA Xiang-qian. Preparation of new hydrogels and their synergistic effects of immunochemotherapyJ. Acta Pharmaceutica Sinica, 2025, 60(2): 479-487. DOI: 10.16438/j.0513-4870.2024-0658

新型水凝胶的制备及其发挥免疫化疗协同作用的研究

Preparation of new hydrogels and their synergistic effects of immunochemotherapy

  • 摘要: 近年来癌症的治疗方法和手段越来越多样化, 单一的治疗方法往往疗效有限, 而免疫联合化疗的协同作用可以更有效抑制肿瘤生长。基于此, 作者构建了一种负载化疗药和肿瘤疫苗的海藻酸钠(sodium alginate, SA) 水凝胶复合体系(命名为SA-DOX-NA), 以期实现化疗药物和肿瘤疫苗的联合使用。首先, 以鸡卵清蛋白(ovalbumin, OVA) 为模型抗原, 选择丙烯酰胺、甲基丙烯酸二甲氨乙酯单体, 通过原位聚合法构建了一种酸性条件下可降解的肿瘤疫苗(命名为NA), 然后以海藻酸钠为基质制备了一种共负载化疗药多柔比星(doxorubicin, DOX) 和NA的水凝胶复合体系SA-DOX-NA。电镜结果显示, SA-DOX-NA具有良好的原位成胶能力, 内部连通性良好, 形成的三维立体网状结构能实现DOX与NA的共负载及药物缓慢释放。抗肿瘤及其免疫调节结果显示, SA-DOX-NA既能有效抑制肿瘤细胞的生长, 又可以实现无外加佐剂的情况下高效促进DC2.4树突状细胞的增殖及活化。综上所述, SA-DOX-NA发挥了化疗及免疫治疗肿瘤的双重功效, 在肿瘤局部治疗中具有良好的应用前景。

     

    Abstract: In recent years, cancer treatment methods and means are becoming more and more diversified, and single treatment methods often have limited efficacy, while the synergistic effect of immunity combined with chemotherapy can inhibit tumor growth more effectively. Based on this, we constructed a sodium alginate hydrogel composite system loaded with chemotherapeutic agents and tumor vaccines (named SA-DOX-NA) with a view to the combined use of chemotherapeutic agents and tumor vaccines. Firstly, the tumor vaccine (named NA) degradable under acidic conditions was constructed by in situ polymerization using chicken ovalbumin (OVA), acrylamide (AAM) and 2-(dimethylamino) ethyl methacrylate (DMAEMA) monomer. Then a hydrogel composite system SA-DOX-NA co-loaded with chemotherapeutic drug doxorubicin (DOX) and NA was prepared using sodium alginate as a matrix. The results showed that SA-DOX-NA had good in situ gel-forming ability and formed a mesh structure that could realize the co-loading of DOX and NA as well as the slow drug release. The electron microscopy results showed that SA-DOX-NA had good in situ gel-forming ability with good internal connectivity, and the three-dimensional mesh structure could realize the co-loading of DOX and NA as well as the slow drug release. The antitumor and immunomodulatory results showed that SA-DOX-NA both effectively inhibited the growth of tumor cells and efficiently promoted the proliferation and activation of DC2.4 dendritic cells without additional adjuvant. In summary, SA-DOX-NA exerts the dual efficacy of chemotherapy and immunotherapy for tumor treatment, and has a good application prospect in local tumor treatment.

     

/

返回文章
返回